Informatics

Laura Marozsan, Scientific Marketing Specialist, Thermo Fisher Scientific, outlines the benefits  of automation in drug discovery. Automation plays a crucial role in modern drug discovery, enabling improvements in efficiency, standardisation, reproducibility and data integrity. An effective automated laboratory contains two main components, physical automation and a unified digital infrastructure. While physical instruments automate the analyses […]

Ahead of the return of CPhI North America, Informa Markets has commissioned an in-depth report into the US pharma market focusing on how the pandemic has affected public discourse and political priorities, and how it could alter the pharmaceutical supply paradigm in the medium term. Analysis from six leading US experts – following extensive interviews […]

You’re about to embark on a journey of discovery. And like all journeys that are worthwhile, it’s far from linear. The process of antibody discovery and development into a clinical candidate is one full of twists, turns, roundabouts, and offshoots, yet one that an increasing number of researchers and companies, both small and large, have […]

Biotechnology company PerkinElmer has announced its documentation, workflow and decision-making informatics platform, Signals, is expanding to build on existing capabilities in the biologics drug discovery space. This comes through a collaboration with Insightful Science, a software company serving the global life sciences community. With the collaboration, pharmaceutical and academic research teams can combine the power […]

Jane Theaker, Kinomica explains why she was so impressed with the preclinical datasets predicting for drug response that the company could produce, she decided to join as CEO. Kinomica is a spin out offering phosphoproteomic analyses to the pharmaceutical industry. Theaker has R&D expertise in novel diagnostic technologies. Her experience includes genomics with AstraZeneca and […]